Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory

Table 2 Participant demographics

	Group
Demographic	NF1	CON
Age (M ± SD (range))	13.03 ± 1.66 (11.33–16.92) years	13.34 ± 1.61 (11.25–16.58) years
Sex (male/female)	9/7	9/7
NF1 mutation (inherited/de novo)	7/9	N/A
Medication	Melatonin (n = 2) Methylphenidate (n = 4)	N/A
Pre-existing clinical diagnoses	ADHD and ASD (n = 3) ADHD (n = 1) ASD (n = 2)	N/A

ISSN: 1866-1955